Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S98
DOI: 10.1016/j.ijrobp.2026.06.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Y.J. Cao und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cao, Y., Li, C., Zhang, S., Sun, X., Chen, J., & Yuan, Z. (2026). Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives. International Journal of Radiation Oncology*Biology*Physics, 126(1), S98. https://doi.org/10.1016/j.ijrobp.2026.06.125
Vancouver
Cao Y, Li C, Zhang S, Sun X, Chen J, Yuan Z. Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S98. doi:10.1016/j.ijrobp.2026.06.125
BibTeX
@article{Cao2026,
author = {Cao, Y.J. and Li, C. and Zhang, S. and Sun, X. and Chen, J.J. and Yuan, Z.},
title = {Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S98},
doi = {10.1016/j.ijrobp.2026.06.125}
}
EUVIMED